Table 3 Cardiovascular Magnetic Resonance (CMR) findings in COVID-19 patients and controls
CMR feature | COVID (n = 27) | Control (n = 27) | p |
|---|---|---|---|
LVEDV/BSA, mean (SD), ml/m2 | 74.2 (17.4) | 67.7 (11.6) | 0.114 |
LVESV/BSA, mean (SD), ml/m2 | 37.8 (12.6) | 26.1 (6.1) | < 0.001 |
LVSV/BSA, mean (SD), ml/m2 | 36.4 (7.1) | 41.6 (8.3) | 0.016 |
LVEF, mean (SD), % | 50.3 (7.2) | 61.3 (6.3) | < 0.001 |
LVEF < 50%, No. (%) | 13 (48.2) | 0 (0) | < 0.001 |
LV mass/BSA, mean (SD), g/m2 | 62.8 (10.9) | 52.4 (9.2) | 0.001 |
RVEDV/BSA, mean (SD), ml/m2 | 77.0 (14.2) | 73.3 (14.7) | 0.322 |
RVESV/BSA, mean (SD), ml/m2 | 40.3 (12.0) | 33.2 (10.1) | 0.023 |
RVSV/BSA, mean (SD), ml/m2 | 37.0 (7.0) | 40.6 (8.6) | 0.096 |
RVEF, mean (SD), % | 48.8 (8.2) | 55.7 (8.1) | 0.003 |
Native T1, mean (SD), ms | 1032 (40) | 996 (29) | < 0.001 |
Native T1 > 1027 ms, No. (%) | 11 (40.7) | 3 (11.1) | 0.013 |
T2, mean (SD), ms | 52.2 (3.8) | 47.2 (2.0) | < 0.001 |
T2 > 49.9 ms, No. (%) | 14 (51.9) | 0 (0) | < 0.001 |
ECV, mean (SD), % | 28.435 (9.9) | 24.3 (2.3) | 0.001 |
ECV > 29.5%, No. (%) | 10 (43.5) | 1 (3.7) | 0.002 |
Edema on STIR, No. (%) | 10 (37.0) | 0 (0) | < 0.001 |
LGE, No. (%) | 12 (44.4) | 0 (0) | < 0.001 |
Ischemic pattern, No. (%) | 3 (25) | – | – |
Non-ischemic pattern, No. (%) | 9 (75) | – | – |
Pericardial enhancement, No. (%) | 2 (7.41) | 0 (0) | 0.15 |